Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria

Primaquine and tafenoquine are the only licensed drugs with activity against Plasmodium vivax hypnozoites but cause haemolysis in patients with glucose–6–phosphate dehydrogenase (G6PD) deficiency. Malaria also causes haemolysis, leading to the replacement of older erythrocytes with low G6PD activity...

Descripción completa

Detalles Bibliográficos
Autores principales: Ley, Benedikt, Alam, Mohammad Shafiul, Satyagraha, Ari Winasti, Phru, Ching Swe, Thriemer, Kamala, Tadesse, Dagimawie, Shibiru, Tamiru, Hailu, Asrat, Kibria, Mohammad Golam, Hossain, Mohammad Sharif, Rahmat, Hisni, Poespoprodjo, Jeanne R., Khan, Wasif Ali, Simpson, Julie A., Price, Ric N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094517/
https://www.ncbi.nlm.nih.gov/pubmed/35544453
http://dx.doi.org/10.1371/journal.pntd.0010406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094517/
https://www.ncbi.nlm.nih.gov/pubmed/35544453
http://dx.doi.org/10.1371/journal.pntd.0010406

Ejemplares similares